Urate-Lowering Therapy in Moderate to Severe Chronic Kidney Disease.

CONCLUSION: Patients who achieve an American College of Rheumatology target sUA below 6 mg/dL during ULT have higher rates of eGFR improvement, especially in CKD Stages 2 and 3. PMID: 30201087 [PubMed - in process]
Source: The Permanente journal - Category: General Medicine Tags: Perm J Source Type: research